The hyper-consolidation, with little to no regulatory oversight, creates inappropriate negotiating leverage that discourages competition and makes it difficult to achieve transparency, affordability, and timely access for patients.
Menendez criticizes the lack of oversight in the PBM market.
Share
More from Bob Menendez
I was not present during Roll Call No. 474. Had I been present, I would have voted YEA on Roll Call No. 474. ____________________
23 years ago, the events of 9/11 forever changed our Nation. Family members, friends, neighbors, and loved ones left their homes that morning never to return. Firefighters from across our district answered the call that day. Port Authority…
I appreciate your partnership. I appreciate you putting the full weight of the Department behind this issue.
It is undeniable that it has reestablished the United States' position as a reliable global partner.
Other voices in this conversation
